CVS · CVS Health Corporation
$73.492026-05-17Sector: Healthcare; Industry: Medical - Healthcare Plans; Sub-Industry: Health Care Services
Intrinsic Value Range Comparison · Mulya.ai
Bull
$495
+573.1% vs market
Base · active
$278
+277.9% vs market
Bear
$275
+274.2% vs market
Mulya.ai vs Analyst IV Comparison?
Mulya.ai IV range ($275 · $495) Analysts Range ($90 · $103) Fundamentals · historical + forward · baseitalics = DCF projection
| Period | Revenue | Rev Gr ? | Ops M% ? | Tax Rate ? | NOPAT ? | Reinvest ? | FCFF ? | WACC% ? | PV FCFF ? | ROIC ? | Inv. Cap ? | EPS ? | P/E |
|---|
| 2021.Q4 | $292.1B | — | 4.6% | 24.2% | $10.1B | $5.8B | $15.9B | 4.5% | — | 8.4% | $120.4B | $6.27 | — |
| 2022.Q4 | $322.5B | 10.4% | 2.5% | 25.9% | $5.9B | $7.0B | $12.9B | 6.0% | — | 5.1% | $109.7B | $3.38 | — |
| 2023.Q4 | $357.8B | 10.9% | 3.8% | 25.1% | $10.3B | −$15.3B | −$5.0B | 5.8% | — | 8.6% | $128.4B | $6.53 | — |
| 2024.Q4 | $372.8B | 4.2% | 2.3% | 25.4% | $6.4B | $1.8B | $8.2B | 6.6% | — | 4.9% | $132.6B | $3.61 | — |
| 2025.Q4 | $402.1B | 7.8% | 1.2% | 19.1% | $3.8B | −$3.2B | $604MM | 7.3% | — | 2.7% | $143.2B | $1.38 | 20.1 |
| italics below = DCF projection · 10yr Rev CAGR: 4.2% |
| 2026.Q4 | $404.9B | +0.7% | 2.6% | 19.2% | $8.5B | −$3.2B | $5.3B | 8.1% | $4.9B | 5.9% | $146.4B | $6.65 | 11.1 |
| 2027.Q4 | $424.6B | +4.9% | 2.8% | 19.3% | $9.6B | −$12.9B | −$3.3B | 8.1% | −$2.8B | 6.3% | $159.3B | $7.53 | 9.8 |
| 2028.Q4 | $447.9B | +5.5% | 3.2% | 19.4% | $11.5B | −$10.7B | $808MM | 8.2% | $639MM | 7.0% | $170.0B | $9.04 | 8.1 |
| 2029.Q4 | $475.4B | +6.1% | 3.2% | 19.5% | $12.3B | −$21.3B | −$9.0B | 8.2% | −$6.6B | 6.8% | $191.4B | $9.62 | 7.6 |
| 2030.Q4 | $495.6B | +4.3% | 3.2% | 19.6% | $12.8B | −$14.3B | −$1.5B | 8.3% | −$1.0B | 6.5% | $205.7B | $10.02 | 7.3 |
|
| Term. Yr+ | $632.6B | 4.1% | 10.9% | 20.0% | $55.0B | −$17.2B | $37.8B | 8.6% | $378.5B | 13.1% | — | — | — |
Active scenario IV: $278 (+277.9% vs market)